358 related articles for article (PubMed ID: 15064337)
1. Comparison of urokinase, alteplase, and reteplase for catheter-directed thrombolysis of deep venous thrombosis.
Grunwald MR; Hofmann LV
J Vasc Interv Radiol; 2004 Apr; 15(4):347-52. PubMed ID: 15064337
[TBL] [Abstract][Full Text] [Related]
2. The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions.
Sugimoto K; Hofmann LV; Razavi MK; Kee ST; Sze DY; Dake MD; Semba CP
J Vasc Surg; 2003 Mar; 37(3):512-7. PubMed ID: 12618684
[TBL] [Abstract][Full Text] [Related]
3. Catheter-directed thrombolysis in deep venous thrombosis with use of reteplase: immediate results and complications from a pilot study.
Castaneda F; Li R; Young K; Swischuk JL; Smouse B; Brady T
J Vasc Interv Radiol; 2002 Jun; 13(6):577-80. PubMed ID: 12050297
[TBL] [Abstract][Full Text] [Related]
4. Reteplase in the treatment of peripheral arterial and venous occlusions: a pilot study.
Ouriel K; Katzen B; Mewissen M; Flick P; Clair DG; Benenati J; McNamara TO; Gibbens D
J Vasc Interv Radiol; 2000; 11(7):849-54. PubMed ID: 10928520
[TBL] [Abstract][Full Text] [Related]
5. Regarding "The safety, efficacy and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions".
Manfredini R; Boari B; Gallerani M; Portaluppi F; Mehta RH
J Vasc Surg; 2003 Aug; 38(2):411-2. PubMed ID: 12894792
[No Abstract] [Full Text] [Related]
6. Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators.
Bode C; Smalling RW; Berg G; Burnett C; Lorch G; Kalbfleisch JM; Chernoff R; Christie LG; Feldman RL; Seals AA; Weaver WD
Circulation; 1996 Sep; 94(5):891-8. PubMed ID: 8790022
[TBL] [Abstract][Full Text] [Related]
7. Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thrombosis.
Vedantham S; Vesely TM; Sicard GA; Brown D; Rubin B; Sanchez LA; Parti N; Picus D
J Vasc Interv Radiol; 2004 Jun; 15(6):565-74. PubMed ID: 15178716
[TBL] [Abstract][Full Text] [Related]
8. Comparison of retavase and urokinase for management of spontaneous subclavian vein thrombosis.
Gelabert HA; Jimenez JC; Rigberg DA
Ann Vasc Surg; 2007 Mar; 21(2):149-54. PubMed ID: 17349354
[TBL] [Abstract][Full Text] [Related]
9. Time to treatment and cost of thrombolysis: a multicenter comparison of tPA and rPA.
Seyedroudbari A; Kessler ER; Mooss AN; Wundeman RL; Bala M; Hilleman DE
J Thromb Thrombolysis; 2000 Apr; 9(3):303-8. PubMed ID: 10728031
[TBL] [Abstract][Full Text] [Related]
10. Patency trials with reteplase (r-PA): what do they tell us?
Bode C; Nordt TK; Peter K; Smalling RW; Runge MS; Kübler W
Am J Cardiol; 1996 Dec; 78(12A):16-9. PubMed ID: 8990406
[TBL] [Abstract][Full Text] [Related]
11. Catheter-Directed Thrombolysis With a Continuous Infusion of Low-Dose Alteplase for Subacute Proximal Venous Thrombosis: Efficacy and Safety Compared to Urokinase.
Gong M; He X; Song J; Zhao B; Shi W; Chen G; Gu J
Clin Appl Thromb Hemost; 2018 Nov; 24(8):1333-1339. PubMed ID: 29768935
[TBL] [Abstract][Full Text] [Related]
12. Thrombosed hemodialysis grafts: lyse and wait with tissue plasminogen activator or urokinase compared to mechanical thrombolysis with the Arrow-Trerotola Percutaneous Thrombolytic Device.
Vogel PM; Bansal V; Marshall MW
J Vasc Interv Radiol; 2001 Oct; 12(10):1157-65. PubMed ID: 11585881
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of reteplase in the treatment of thrombosed hemodialysis venous catheters.
Castner D
Nephrol Nurs J; 2001 Aug; 28(4):403-4, 407-10. PubMed ID: 12143462
[TBL] [Abstract][Full Text] [Related]
14. Catheter-directed thrombolysis for the management of postpartum deep venous thrombosis.
Acharya G; Singh K; Hansen JB; Kumar S; Maltau JM
Acta Obstet Gynecol Scand; 2005 Feb; 84(2):155-8. PubMed ID: 15683376
[TBL] [Abstract][Full Text] [Related]
15. Safety of catheter-directed thrombolysis for deep venous thrombosis in cancer patients.
Kim HS; Preece SR; Black JH; Pham LD; Streiff MB
J Vasc Surg; 2008 Feb; 47(2):388-94. PubMed ID: 18241762
[TBL] [Abstract][Full Text] [Related]
16. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group.
Zeymer U; Tebbe U; Essen Rv; Haarmann W; Neuhaus KL
Am Heart J; 1999 Jan; 137(1):34-8. PubMed ID: 9878934
[TBL] [Abstract][Full Text] [Related]
17. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry.
Mewissen MW; Seabrook GR; Meissner MH; Cynamon J; Labropoulos N; Haughton SH
Radiology; 1999 Apr; 211(1):39-49. PubMed ID: 10189452
[TBL] [Abstract][Full Text] [Related]
18. Catheter-directed thrombolysis with a continuous infusion of low-dose urokinase for non-acute deep venous thrombosis of the lower extremity.
Gao B; Zhang J; Wu X; Han Z; Zhou H; Dong D; Jin X
Korean J Radiol; 2011; 12(1):97-106. PubMed ID: 21228945
[TBL] [Abstract][Full Text] [Related]
19. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D
J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
[TBL] [Abstract][Full Text] [Related]
20. Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life.
Comerota AJ; Throm RC; Mathias SD; Haughton S; Mewissen M
J Vasc Surg; 2000 Jul; 32(1):130-7. PubMed ID: 10876214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
